Daily Times Speaker empowered to constitute body comprising members from both opposition and treasury benches House passes eight resolutions to extend as many ordinances
April 2, 2021
The National Assembly on Thursday debated setting up of a parliamentary committee on electoral reforms to bring improvement and transparency in general elections in 2023.
Minister of State for Parliamentary Affairs Ali Muhammad Khan moved a motion, empowering the National Assembly speaker to constitute a parliamentary committee comprising members from both opposition and treasury benches on electoral reforms, however the opposition bulldozed the motion.
Shazia Marri of PPP said that similar committee was set up during tenure of past government. The Election Commission of Pakistan (ECP) had framed rules in light of the recommendations given by the committee. She said the ECP was an independent constitutional body but alleged that it was being pressurized. “We have to change our perspective,
SHC clears Sputnik V vaccine for sale in Pakistan
National
April 2, 2021
KARACHI: Sindh High Court (SHC) on Thursday permitted the private company that has imported Russia s Sputnik V COVID-19 vaccine to begin selling it as the country battles an intensifying third coronavirus wave.
The decision came during the hearing of an appeal by the Drug Regulatory Authority of Pakistan (DRAP) against the release of the Sputnik V vaccine. The company s lawyer told the court the government had set the tariff on coronavirus vaccines after his client had already imported the vaccine, therefore, it does not apply to the company s imported vaccine.
Pakistani Company Inks Deal to Manufacture COVID-19 Vaccine
Joe Raedle-Getty Images North America AFP
Searle’s agreement with Livzon Mapharm is linked to a vaccine that is currently in Phase II clinical trials
Pakistani pharmaceutical company Searle has inked a deal with China’s Livzon Mapharm allowing it to license, manufacture, and supply a new COVID-19 vaccine in the country, according to information provided by the company to the Pakistan Stock Exchange.
“Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the Recombinant Novel Coronavirus Vaccine (V-01). The licensing agreement also covers the manufacturing transition of (V-01) in Pakistan,” reads the letter submitted by the company. It said that the vaccines was in the final phases of its clinical trial, adding that early results were promising.
A local pharmaceutical company has signed a deal with a Chinese giant that allowed it to supply and produce an upcoming Covid-19 vaccine in Pakistan. Reuters/File
KARACHI: A local pharmaceutical company has signed a deal with a Chinese giant that allowed it to supply and produce an upcoming Covid-19 vaccine in Pakistan, an official announcement said on Thursday.
This has emerged in a letter written by M/s Searle Company Limited to the Pakistan Stock Exchange, saying it had concluded an agreement with China’s Livzon Mapharm Inc. for manufacturing novel coronavirus vaccine (V-01) in Pakistan.
“Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the Recombinant Novel Coronavirus Vaccine (V-01). The licensing agreement also covers the manufacturing transition of (V-01) in Pakistan,” the company said.
The Drug Regulatory Authority of Pakistan (DRAP) has requested the Sindh High Court (SHC) to bar a private company from selling the Russian coronavirus